[1]
Aksoy, E., Ergenc, Z. and Ergenc, H. 2023. The effects of a Cilostazol, a selective phosphodiesterase III inhibitor, on liver ischemic-reperfusion injury and liver regeneration; In vitro experimental study: The effects of a Cilostazol: In vitro experimental study. Medical Science and Discovery. 10, 8 (Aug. 2023), 546–551. DOI:https://doi.org/10.36472/msd.v10i8.978.